Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Evaxion Biotech gets a go-ahead for phase IIb with EVX-01

One of the big milestones coming for Danish Evaxion Biotech in 2022 is the phase IIb trial initiation with cancer immunotherapy EVX-01. The company has now received clearance from the Australian regulatory body, and the study is expected to start in the second quarter this year. BioStock reached out to Niels Iversen Møller, Co-founder and CBO, to learn more.Read the full article at biostock.se:https://www.biostock.se/en/2022/01/evaxion-biotech-gets-a-go-ahead-for-phase-iib-with-evx-01/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

KEBNI GETS LOCAL REPRESENTATION IN INDONESIA

KebNi AB (publ) has engaged PT Bintang Panca Tridasa as local representative in IndonesiaStockholm, 24 January 2022 - KebNi AB announces today that PT Bintang will act as Market Consultant, potential Re-seller, and local support provider for Kebni products. PT Bintang is a well-established and well reputed Technology Consultant and Support company in Indonesia, with good contacts and relationship with the Government and local industry. By this engagement Kebni strengthens its presence in Indonesia with such a strategic partner as PT Bintang. “We welcome PT Bintang as our new local

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act (BlackRock, Inc.)

Nordea Bank AbpStock exchange release – Major shareholder announcements24 January 2022 at 09.45 EET Nordea Bank Abp has on 21 January 2022 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights has decreased below the threshold of 5 per cent on 20 January 2022. The total number of shares and voting rights in Nordea Bank Abp on 20 January 2022 was 3,965,561,160. The current total number of shares and voting rights in Nordea Bank Abp is 3,930,834,811.

Obducat and Neutronix Quintel (NXQ) Announce Collaboration Agreement

OBDUCAT AB (publ), a leading supplier of lithography processing solutions and nanoimprint lithography (NIL) tools, has entered into collaboration agreement with Neutronix Quintel (NXQ), a world-renowned US-based supplier of mask aligners & photolithography systems. Obducat and NXQ have had a longstanding relationship and mutual technological respect, and this agreement marks the start of a more comprehensive collaboration focused on sales, marketing, service, and support. NXQ will support the sales and marketing activities as well as handle the service and support for Obducat products on

Alfa Laval membrane system generates value from waste

Alfa Laval will supply membrane systems to a food facility in Denmark to produce healthy dietary fibre from crop leftovers. The membranes will extract fibres from sources such as brewers’ grains, corn stover and wheat straw, improving the circularity of the food chain.The Alfa Laval membrane filtration systems will be used  to recover and purify crop leftovers, mainly supplied from local farmers, and process it into prebiotic dietary fibre. These prebiotic fibres are not digestible by the human body but help ensure healthy bacteria growth in the stomach which can help with various digestive

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 21st January 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,180,275 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Scandinavian Biogas invests 300 miljon SEK in northern Europes largest plant for Bio-LNG

The biogas plant in Gladö Kvarn is being expanded to meet the demand for Bio-LNG[Klimatklivet]In the second half of 2023, the expanded plant in Gladö Kvarn on Södertörn just south of Stockholm for the production of liquefied biogas (Bio-LNG) is expected to be completed. The plant will produce 220 GWh of Bio-LNG per year, making it the largest of its kind in northern Europe. The former largest plant is Norwegian Skogn, which is also owned by Scandinavian Biogas. By comparison, 220 GWh corresponds to an energy volume of 22 million liters of diesel. Scandinavian Biogas will invest 300

Basalt, through Ride BidCo AB, completes the offer to the shareholders of Nobina AB (publ) and thereby becomes the owner of 92.8 per cent of the shares [1] and further extends the acceptance period

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa or in any other jurisdiction where such offer would be prohibited by applicable law pursuant to legislation, restrictions and regulations in the relevant jurisdiction. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important notice" at the end of

A Home for a Home Supported More than 20,000 Children in 2021

After only six months, more than 20,000 children have improved life quality through SOS Children’s Villages and Heimstaden’s unique partnership A Home for a Home. With a more than doubled budget in 2022, the partners have high expectations for what they will accomplish.“What we have accomplished in six months normally takes 2-3 years in comparable programs. Everyone in Heimstaden is strongly committed to the program and to create value for children that need it the most,” says Anette Konar Riple, Program Manager for A Home for a Home.  In July 2021, SOS Children’s Villages and Heimstaden

SOTKAMO SILVER AB: SILVER PRODUCTION IN 2021 AND GUIDANCE FOR 2022

Press release: Stockholm, January 24, 2021, 08:15 CET Our silver production of the full year 2021 was 1.38 Moz, which is the same as the updated guidance given on December 9, 2021. Production guidance for 2022: We expect to produce ca. 1.5 million ounces of silver in 2022. However, our primary target is to maximise the revenue and operative cashflow. To achieve this, we adjust the mix of metals in our ore feed which might have an impact to the produced silver ounces. Stockholm, January 24, 2022 Sotkamo Silver AB Erkki Kuronen, CEO   Contact person Erkki Kuronen,

The exercise period for Alzinova's warrants of series TO2 2020/2022 begins today

In October 2020, Alzinova AB (publ) (“Alzinova” or the “Company”) carried out an issue of units with pre-emption rights for the shareholders (the “Rights Issue”), as well as an issue of units without pre-emption rights for the shareholders to the guarantors in the Rights Issue for their guaranteed commitments (the “Directed Issue”). The units issued in the Rights Issue and the Directed Issue consisted of shares and warrants of series TO2 2020/2022 (the “warrants”). The exercise period for the warrants begins today, January 24, 2022 and runs up to and including February 7, 2022. Two (2)

Faron at Proactive One2One Investor Forum

Faron Pharmaceuticals Ltd. ("Faron")   Faron to Present at the Proactive One2One Investor Forum   Press Release, January 24, 2022 at 02:00 AM (EDT) / 07:00 AM (GMT) / 09:00 AM (EET)   TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron, will participate in the Proactive One2One Investor

Fourth subscription period of T01 started

The fourth subscription period started January 22 until February 7, 2022.Insplorion has one outstanding warrant program, TO1 2018/2023 which was distributed to all shareholders in connection with the financing agreement with ESGO, signed at the beginning of 2018. TO1 is traded at Nasdaq First North. For TO1 2018/2023, the subscription price is SEK 11.50. The number of shares that each warrant entitles to subscribe for is 1.033. The recalculation is regulated under § 8 in TERMS OF SUBSCRIPTION OPTIONS IN INSPLORION AB (PUBL) SERIES TO1 2018/2023. The fourth subscription period

SRV Group Plc: Proposals of the Shareholders' Nomination Board to the Annual General Meeting 2022

SRV GROUP PLC     STOCK EXCHANGE RELEASE     24 JANUARY 2022      09:00 EET SRV Group Plc: Proposals of the Shareholders’ Nomination Board to the Annual General Meeting 2022 The Shareholders' Nomination Board of SRV Group Plc submits the following proposals to the Annual General Meeting planned to be held on 28 March 2022: The Nomination Board proposes that five members will be elected to the Board of Directors. The Nomination Board proposes that present members Heli Iisakka, Timo Kokkila, Hannu Leinonen, Heikki Leppänen and Tomi Yli-Kyyny be re-elected as members of the Board

Metso Outotec introduces MDM900, one of the world’s largest mill discharge slurry pumps

Metso Outotec Corporation’s press release on January 24, 2022, at 09:00 a.m. EETMetso Outotec is proud to introduce the Metso Outotec MDM900 mill discharge slurry pump, the latest addition to its flagship Mill Discharge (MD) Pump Series. The massive MDM900 is one of the world’s largest mill discharge slurry pumps, designed for heavy-duty use in concentrator plants, where capacity and wear-resistance are of essence. The MDM900 is an all-metal, thick-walled, extra heavy-duty pump designed specifically for extremely arduous mill duty applications. “Slurry handling is vital in maximizing a

Tokmanni Group Corporation will publish its Financial Statement Bulletin on 11 February 2022

Tokmanni Group Corporation        Investor news        24 January 2022 at 9:00 amTokmanni will publish its Financial Statement Bulletin on 11 February 2022 at approximately 8:30 am (Finnish time). The stock exchange release and the presentation materials in Finnish and in English will be available on the company's website at https://ir.tokmanni.fi/en/investors as soon as possible after the publication of the report. Tokmanni’s President and CEO Mika Rautiainen and CFO Markku Pirskanen will present the review to analysts, investors and media representatives on the publication day at 11:30

Disease-modifying antirheumatic drugs do not seem to protect people with rheumatoid arthritis against Parkinson’s disease

The autoimmune disorder rheumatoid arthritis has been associated with a lower risk of Parkinson’s disease (PD) in previous studies, with antirheumatic drugs as one possible explanation. However, most of the disease-modifying antirheumatic drugs (DMARDs) were not associated with the risk of PD in individuals with rheumatoid arthritis, a new register-based study from the University of Eastern Finland shows. An exception was the use of chloroquine or hydroxychloroquine which associated with a lower risk of PD. The findings were published online on January 21, 2022, in Neurology®, the medical

Vår Energi intends to apply for a listing on Oslo Børs

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE. Sandnes, Norway, 24 January 2022 Vår Energi AS (the “Company,” the “Group” or “Vår Energi”), one of the largest independent upstream oil and gas companies on the Norwegian Continental Shelf (the "NCS"), today announces its intention to launch an initial

Already more than thousand Valio dairy farms have calculated the carbon footprint of their milk production − the calculation provides direction for reducing emissions

The certified Valio Carbo® environmental calculator, developed for the Finnish climate and conditions, is used in monitoring the carbon balance of Valio dairy farms. In 2021, already more than thousand dairy farms, i.e. about a quarter of all Valio dairy farms, calculated the carbon footprint of the milk they produce. The calculated average carbon footprint of the milk produced at Valio dairy farms, i.e. raw milk, is 1.06 kilograms CO2e per litre. What makes the calculations significant is the fact that it covers 35 percent of the milk received by Valio and thus already about 28 percent of

European Parliament proposed amendments to EU ETS put Green Deal goals at risk

Brussels, 24 January 2022 – The European Parliament’s lead MEP on the EU ETS proposes amendments to the ETS for maritime that put the impact and efficiency of the EU Green Deal at risk, says World Shipping Council (WSC).The EU ETS intends to impose a technologically neutral greenhouse gas (GHG) price across all elements of industries like shipping, to incentivize the most cost-effective GHG emissions reductions and innovative solutions. Carbon pricing is a key part of driving adoption of zero-GHG fuels, and the EU ETS can be an important step toward global market-based-measures that would

BuildData – Second quarter results for the period ending 31 December 2021

Q2 Summary Highlights Financial Highlights · Introducing three new KPIs, ARR, TCV and gross profit margin. · ARR at the end of Q2 was SEK 72.1m, corresponding to a 248% increase compared with the same period in FY21 (SEK 20.7m). · Total contract value of SEK 96.5m, corresponding to a 147% increase compared with the same period in FY21 (SEK 39.1m). · Gross profit in Q2 was SEK 21.4m representing 96%  of income. · Net sales in Q2 were SEK 21.7m, corresponding to a 136% increase compared with the same period in FY21 (SEK 9.2m). · Normalised EBITDA (EBITDA before non-

Roshi Motman Appointed CEO of amuse, as Co-founder Diego Farias Steps Down

January 24, 2022 | After 7 years of co-founding and leading the company since its start, Co-founder Diego Farias is now stepping down from his role as CEO. Roshi Motman, who has held the position as amuse’s COO since October 2020, has been appointed new CEO from January 2022.Founded in Stockholm in 2015, next-gen artist services company amuse has attracted artists, creators and management teams across the globe with its digital services and label. Farias’ departure follows several years of growth for amuse, with hundreds of thousands of users distributing their music on the platform and a

AKT blockade against UPM does not advance negotiations

(UPM, Helsinki, 22 January 2022 at 11:45 EET) – The Transport Workers’ Union AKT has today announced a blockade against UPM in Finland to support the strikes of the Paperworkers’ Union and the Finnish Electrical Workers´ Union. AKT’s support measures will be carried out as a blockade in Finnish ports. During the blockade, the stevedores will not handle UPM’s paper and pulp. The blockade will begin on 24 January at 06:00. “AKT’s actions do not advance functioning labour markets. AKT is not even a party in the negotiations, which we aim to start with the Paperworkers’ Union,” says Jyrki

Nordea Bank Abp: Repurchase of own shares on 21.01.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares21.01.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 21.01.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 1,107,955 10.27 11,383,084.76XHEL 829,892 10.28 8,534,941.28CEUX 913,109 10.31 9,413,161.06AQEU 155,185 10.25

There are no items matching the current filter
There are no more items matching the current filter
Back to top